Safety Study of a New Drug Combination in Healthy Volunteers
Part of Heart & circulation, Hormones & metabolism clinical trials.
This early-stage study tests a new investigational drug called AD-231 to see how safe it is and how your body processes it. Researchers will compare it to a combination of three related drugs to understand which approach works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 19 and 64 years old at the time you join
- Have a healthy weight (BMI between 18.0 and 30.0)
- Be in generally good health with no serious medical conditions
- Not have participated in another drug study within the past 6 months
- Be willing to have blood samples taken and follow study visit schedules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
This trial studies how two experimental drugs (AD-2321 and AD-2322) interact in the body and if they are safe for healthy volunteers. It is a Phase 1 study open to healthy adults.
This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.
This study tests how two experimental drugs, called AD-236A and AD-236B, interact in the body and checks if they are safe. Healthy volunteers are needed to see how the drugs affect each other.
This trial compares how the body processes two different forms of the same drug, AD-117 and AD-117A, and checks for safety. It's for healthy adults to help ensure the drug works similarly and safely.
This early-stage trial tests how a new drug called AD-230 moves through the body and whether it's safe in healthy volunteers. Researchers will measure drug levels in your blood and watch for any side effects.
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.